NCCN Oncology Policy Summits

Oncology-Policy-Summits-web-header

Defining the "New Normal"— 2021 and the State of Cancer Care in America Following 2020


June 15, 2021 | 10:00 am – 2:00 pm EDT

Register Now    View Full Agenda

 

This FREE online program will explore how national health and sociopolitical events in 2020 will impact future cancer care delivery in the United States. Convening a group of diverse speakers and panelists, the virtual summit will discuss the influence of watershed events including the COVID-19 pandemic, post-election landscape, and national conversations of racial inequity on cancer care.

Supporters

Supported by Adaptive, ADC Therapeutics, AmerisourceBergen, Apobiologix, Astellas, BeiGene, Ltd., BMS, bluebird bio, Boehringer Ingelheim Pharmaceuticals, Inc., Eisai Inc, EMD Serono, Epizyme, EQRx, Exelixis, Foundation Medicine, Inc., GSK, Helsinn, Heron, Incyte Corporation, Janssen Oncology, Kite, a Gilead Company, MorphoSys US, Inc., Regeneron Pharmaceuticals, Inc., QED Therapeutics, Sun Pharma Oncology, and TG Therapeutics. Supported by AstraZeneca through its NCCN Corporate Council Membership. Supported by an independent educational grant from Merck & Co., Inc. This event is sponsored by Lilly Oncology. This activity was made possible by Pharmacyclics, an AbbVie Company.

Upcoming events: Save the dates!

  • Thursday, September 9, 2021 – NCCN Policy Summit: The Impact of Technology on Cancer Care in 2021
  • Tuesday, December 7, 2021 – NCCN Patient Advocacy Summit: Advancements in Precision Medicine and Implications for Quality, Accessible, and Equitable Cancer Care

Previous Policy Summits

2020 series

  • Innovative Solutions to Drive Down Healthcare Costs: Implications for Access to High-Quality Cancer Care: Article coming soon
  • Accelerating Advances in Cancer Care Research: A Lookback at the 21st Century Cures Act in 2020: View video | View article

2019 series

  • Delivering Value for Patients across the Oncology Ecosystem: View article
  • Defining, Measuring, and Applying Quality in an Evolving Health Policy Landscape and the Implications for Cancer Care: View article
  • The State of Cancer Care in America: The Impact of State Policy on Access to High-Quality Cancer Care: View article